These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 15331904)

  • 1. Role of Basic Fibroblast Growth Factor in Cancer: Biological Activity, Targeted Therapies, and Prognostic Value.
    Ardizzone A; Bova V; Casili G; Repici A; Lanza M; Giuffrida R; Colarossi C; Mare M; Cuzzocrea S; Esposito E; Paterniti I
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer.
    Smolensky D; Rathore K; Cekanova M
    Drug Des Devel Ther; 2016; 10():3305-3322. PubMed ID: 27784990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the angiogenic components, VEGFA, FGF2, OPN and RHOC, in urothelial cell carcinoma of the urinary bladder.
    Zaravinos A; Volanis D; Lambrou GI; Delakas D; Spandidos DA
    Oncol Rep; 2012 Oct; 28(4):1159-66. PubMed ID: 22895562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spotlight on differentially expressed genes in urinary bladder cancer.
    Zaravinos A; Lambrou GI; Volanis D; Delakas D; Spandidos DA
    PLoS One; 2011 Apr; 6(4):e18255. PubMed ID: 21483670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urine-based markers of angiogenesis in bladder cancer].
    Becker M; Tilki D; Szarvas T; Rübben H; Ergün S
    Urologe A; 2009 Jun; 48(6):609-14. PubMed ID: 19557465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target.
    Knowles MA
    World J Urol; 2007 Dec; 25(6):581-93. PubMed ID: 17912529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer.
    Kwak C; Ku JH; Park JY; Lee E; Lee SE; Lee C
    J Urol; 2004 Jan; 171(1):149-52. PubMed ID: 14665864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of angiogenesis in urothelial bladder carcinoma.
    Fus ŁP; Górnicka B
    Cent European J Urol; 2016; 69(3):258-263. PubMed ID: 27729991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.
    Durkan GC; Nutt JE; Rajjayabun PH; Neal DE; Lunec J; Mellon JK
    Clin Cancer Res; 2001 Nov; 7(11):3450-6. PubMed ID: 11705862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancer.
    O'Brien T; Cranston D; Fuggle S; Bicknell R; Harris AL
    Cancer Res; 1997 Jan; 57(1):136-40. PubMed ID: 8988054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic role of basic fibroblast growth factor in Wilms' tumor patients.
    Lin RY; Argenta PA; Sullivan KM; Adzick NS
    Clin Cancer Res; 1995 Mar; 1(3):327-31. PubMed ID: 9815988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
    Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary basic fibroblast growth factor in patients with bladder cancer and benign prostatic hypertrophy.
    O'Brien TS; Smith K; Cranston D; Fuggle S; Bicknell R; Harris AL
    Br J Urol; 1995 Sep; 76(3):311-4. PubMed ID: 7551838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary basic fibroblast growth factor in bladder cancer patients. Histopathological correlation and clinical potential.
    Gravas S; Bosinakou I; Kehayas P; Giannopoulos A
    Urol Int; 2004; 73(2):173-7. PubMed ID: 15331904
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.